FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer

Ovarian cancer (OC) is the fifth most common cause of cancer death. More than 40% are older than 70 years. The standard treatment is radical surgery combined with chemotherapy. More than 40% of the Danish patients will never undergo surgery. Frail and immunodeficient older patients are at higher risk of complications, and immunomodulating treatment as chemotherapy results in different outcomes in comparable patients. No accurate validated screening tool to identify frail and immunodeficient OC women exists. Optimization through comprehensive geriatric assessment (CGA) and physical training bef

Trial Details

NCT ID
NCT05810701
Phase
NA
Sponsor
Odense University Hospital
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Comprehensive geriatric assessment and individualised physical training
Locations (sample)
  • Odense, Region of South Denmark, Denmark|55.39594,10.38831
  • Vejle, Region of South Denmark, Denmark|55.70927,9.5357
  • Roskilde, Region Sjælland, Denmark|55.64152,12.08035
  • Copenhagen, The Capital Region of Denmark, Denmark|55.67594,12.56553
  • Herlev, The Capital Region of Denmark, Denmark|55.72366,12.43998

Key Eligibility Criteria

  • Newly diagnosed ovarian cancer
  • Capable of understanding written and oral danish

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →